Humana INC (Put) (HUM) Holder Equitec Proprietary Markets LLC Has Upped Position by $4.51 Million as Share Value Rose

April 17, 2018 - By Clifton Ray

Humana Inc. (NYSE:HUM) LogoInvestors sentiment decreased to 1.05 in Q4 2017. Its down 0.16, from 1.21 in 2017Q3. It worsened, as 40 investors sold HUM shares while 209 reduced holdings. 69 funds opened positions while 193 raised stakes. 125.53 million shares or 4.46% less from 131.39 million shares in 2017Q3 were reported. Moreover, State Of New Jersey Common Pension Fund D has 0.21% invested in Humana Inc. (NYSE:HUM) for 225,000 shares. Fil Ltd accumulated 568,953 shares. Artisan Prtnrs Limited Partnership invested in 0.03% or 58,524 shares. Legal General Grp Public Ltd Llc invested 0.14% in Humana Inc. (NYSE:HUM). Earnest Ptnrs Limited Liability accumulated 0.3% or 126,469 shares. Torch Wealth Ltd Limited Liability Company invested in 9,748 shares. 3,824 are held by Wetherby Asset. One Natl Association has invested 0.14% in Humana Inc. (NYSE:HUM). Leuthold Ltd Liability Corporation holds 0.95% or 38,525 shares in its portfolio. Td Asset Mgmt reported 149,951 shares or 0.05% of all its holdings. Pitcairn, Pennsylvania-based fund reported 2,663 shares. Scout reported 54,080 shares stake. Fuller & Thaler Asset Management has 1,300 shares for 0% of their portfolio. Laurion Cap Mngmt LP accumulated 72,585 shares. Vident Investment Advisory Lc has 21,278 shares for 0.24% of their portfolio.

Since December 15, 2017, it had 0 insider buys, and 10 insider sales for $20.82 million activity. 7,054 shares were sold by BILNEY JODY L, worth $1.75M on Friday, December 15. Another trade for 12,719 shares valued at $3.49M was made by LeClaire Brian P. on Saturday, February 24. BROUSSARD BRUCE D sold $3.86 million worth of Humana Inc. (NYSE:HUM) on Saturday, February 24. 1,073 Humana Inc. (NYSE:HUM) shares with value of $295,450 were sold by Fleming William Kevin. 1,382 shares were sold by Huval Timothy S., worth $340,034. Another trade for 16,389 shares valued at $4.48 million was sold by Christopher M Todoroff.

Equitec Proprietary Markets Llc increased its stake in Humana Inc (Put) (HUM) by 209.2% based on its latest 2017Q4 regulatory filing with the SEC. Equitec Proprietary Markets Llc bought 18,200 shares as the company’s stock rose 9.24% while stock markets declined. The institutional investor held 26,900 shares of the medical specialities company at the end of 2017Q4, valued at $6.67M, up from 8,700 at the end of the previous reported quarter. Equitec Proprietary Markets Llc who had been investing in Humana Inc (Put) for a number of months, seems to be bullish on the $40.91 billion market cap company. The stock increased 2.19% or $6.34 during the last trading session, reaching $296.29. About 1.14 million shares traded or 6.91% up from the average. Humana Inc. (NYSE:HUM) has risen 31.54% since April 17, 2017 and is uptrending. It has outperformed by 19.99% the S&P500.

Humana Inc. (NYSE:HUM) Ratings Coverage

Among 13 analysts covering Humana Inc (NYSE:HUM), 9 have Buy rating, 0 Sell and 4 Hold. Therefore 69% are positive. Humana Inc had 24 analyst reports since October 23, 2017 according to SRatingsIntel. The rating was maintained by RBC Capital Markets with “Hold” on Thursday, February 8. The firm earned “Hold” rating on Friday, March 30 by Cantor Fitzgerald. The stock of Humana Inc. (NYSE:HUM) earned “Hold” rating by Credit Suisse on Friday, November 3. The rating was maintained by Leerink Swann on Monday, November 27 with “Buy”. The firm earned “Neutral” rating on Monday, February 12 by JP Morgan. The company was maintained on Friday, November 10 by Credit Suisse. The rating was maintained by Morgan Stanley with “Overweight” on Thursday, November 9. On Wednesday, February 7 the stock rating was maintained by Piper Jaffray with “Buy”. The firm has “Outperform” rating given on Friday, November 10 by BMO Capital Markets. The stock has “Buy” rating by Leerink Swann on Thursday, February 8.

Humana Inc. (NYSE:HUM) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.